Trials / Completed
CompletedNCT04008914
Readmission Risk Factors and Heart Failure With Preserved Ejection Fraction
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 492 (actual)
- Sponsor
- Ascension Macomb-Oakland Hospital · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Retrospective review of 492 patient from a small community hospital who did not qualify for participation in the Connect HF study sponsored by DCRI.
Detailed description
Retrospective review of adults above the age of 18 with a primary diagnosis of HFpEF between August 2017 and March 2018. Subjects had to fall into one of two classifications (NYHA Class II-IV or ACC/AHA Stage B-D) and had a life expectancy greater than 6 months are included. Individuals with a terminal illness other than HF, prior heart transplant or on a transplant list, or current/ planned left ventricular assist device excluded. The primary objective of this study is to identify risk factors for readmission in patients discharged with a diagnosis of HFpEF.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | retrospective observation | Retrospective review of study patients excluded from the CONNECT- HF trial who were discharged with a diagnosis of HFpEF between August 1, 2017 and March 1, 2018. Readmission rate at 30 and 90 days along with patient demographics and associated comorbidities were analyzed. |
Timeline
- Start date
- 2017-08-01
- Primary completion
- 2018-03-01
- Completion
- 2019-01-18
- First posted
- 2019-07-05
- Last updated
- 2019-07-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04008914. Inclusion in this directory is not an endorsement.